# GSK (GSK) — Analyst Forecast

GSK · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/gsk/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 24, 2026 | Citigroup | Maintained | Neutral | — |
| Jan 6, 2026 | Barclays | Downgraded | Equal-Weight → Underweight | — |
| Oct 27, 2025 | Jefferies | Initiated Coverage | Hold → Buy | — |
| Nov 12, 2024 | Jefferies | Downgraded | Buy → Hold | — |
| Oct 31, 2024 | Guggenheim | Downgraded | Buy → Neutral | — |
| Jul 8, 2024 | UBS | Downgraded | Buy → Neutral | — |
| Jul 2, 2024 | Jefferies | Maintained | Buy | $53.00 |
| May 30, 2024 | Goldman Sachs | Initiated Coverage | Neutral | $47.00 |
| Mar 4, 2024 | Guggenheim | Upgraded | Neutral → Buy | — |
| Jan 23, 2024 | Morgan Stanley | Initiated Coverage | Equal-Weight | $44.00 |
| Jan 3, 2024 | Jefferies | Upgraded | Hold → Buy | $48.00 |

## Frequently Asked Questions

### What is the latest analyst rating on GSK?

On Jul 24, 2026, Citigroup maintained GSK at Neutral.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).